Literature DB >> 9281450

Ischemic preconditioning and morphine-induced cardioprotection involve the delta (delta)-opioid receptor in the intact rat heart.

J J Schultz1, A K Hsu, G J Gross.   

Abstract

Several investigators have demonstrated that the opioid pathway is involved in tissue preservation during hypoxia or ischemia and that this protection is mediated via the delta (delta)-opioid receptor. Subsequently, we have shown that opioid receptors are involved in ischemic preconditioning (PC) in the rat heart and that morphine produces a cardioprotective effect; however, the class of opioid receptors involved in mediating these effects is still unknown. Therefore, the purpose of the present study was to test the hypothesis that ischemia- and morphine-induced cardioprotection are mediated via stimulation of the delta-opioid receptor in the rat heart. Anesthetized, open-chest Wistar rats were subjected to one of six protocols. The control group was subjected to 30 min of occlusion and 2 h of reperfusion. Ischemic PC was elicited by three 5 min occlusion periods interspersed with 5 min of reperfusion. Morphine-induced cardioprotection was produced by three 5 min morphine infusions (100 microg/kg/infusion, i.v.) interspersed with a 5-min drug-free period. To determine if the delta-opioid receptor has a role in ischemic PC and morphine-induced cardioprotection, naltrindole (NTI), a selective delta-opioid receptor antagonist, was utilized. NTI (5 mg/kg, i.v.) was given 10 min prior to ischemic PC (NTI+PC) or morphine infusion (NTI+MOR). Also, NTI (5 mg/kg, i.v.) was given 10 min before the 30 min occlusion period in untreated rats. Infarct size (IS) as a percent of the area at risk (AAR) was determined by 2,3,5-triphenyltetrazolium chloride staining. Ischemic PC and morphine infusions resulted in similar reductions in IS/AAR from 51+/-4 to 11+/-3 and 15+/-4% (*P<0.05), respectively. NTI completely abolished the cardioprotective effect induced by ischemia and morphine. The results of the present study suggests a role of delta;-opioid receptors in ischemic PC or morphine-induced myocardial protection in the rat.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9281450     DOI: 10.1006/jmcc.1997.0454

Source DB:  PubMed          Journal:  J Mol Cell Cardiol        ISSN: 0022-2828            Impact factor:   5.000


  40 in total

Review 1.  Protecting the ischaemic and reperfused myocardium in acute myocardial infarction: distant dream or near reality?

Authors:  D M Yellon; G F Baxter
Journal:  Heart       Date:  2000-04       Impact factor: 5.994

Review 2.  Protective transcriptional mechanisms in cardiomyocytes and cardiac fibroblasts.

Authors:  Cameron S Brand; Janet K Lighthouse; Michael A Trembley
Journal:  J Mol Cell Cardiol       Date:  2019-04-28       Impact factor: 5.000

Review 3.  Cardiovascular effects of antiobesity drugs: are the new medicines all the same?

Authors:  Mauro Cataldi; Angelo Cignarelli; Francesco Giallauria; Giovanna Muscogiuri; Luigi Barrea; Silvia Savastano; Annamaria Colao
Journal:  Int J Obes Suppl       Date:  2020-07-20

Review 4.  Opioid-induced cardioprotection.

Authors:  Katsuya Tanaka; Judy R Kersten; Matthias L Riess
Journal:  Curr Pharm Des       Date:  2014       Impact factor: 3.116

Review 5.  Current research on opioid receptor function.

Authors:  Yuan Feng; Xiaozhou He; Yilin Yang; Dongman Chao; Lawrence H Lazarus; Ying Xia
Journal:  Curr Drug Targets       Date:  2012-02       Impact factor: 3.465

6.  Cholesterol reduction by methyl-beta-cyclodextrin attenuates the delta opioid receptor-mediated signaling in neuronal cells but enhances it in non-neuronal cells.

Authors:  Peng Huang; Wei Xu; Su-In Yoon; Chongguang Chen; Parkson Lee-Gau Chong; Lee-Yuan Liu-Chen
Journal:  Biochem Pharmacol       Date:  2006-11-03       Impact factor: 5.858

7.  Eribis peptide 94 reduces infarct size in rat hearts via activation of centrally located μ opioid receptors.

Authors:  Garrett J Gross; Anna Hsu; Kasem Nithipatikom; Irina Bobrova; Erik Bissessar
Journal:  J Cardiovasc Pharmacol       Date:  2012-02       Impact factor: 3.105

8.  Comparative analysis of the cardioprotective properties of opioid receptor agonists in a rat model of myocardial infarction.

Authors:  Leonid N Maslov; Yury B Lishmanov; Peter R Oeltgen; Eva I Barzakh; Andrey V Krylatov; Natalia V Naryzhnaya; Jian-Ming Pei; Stephen A Brown
Journal:  Acad Emerg Med       Date:  2010-11       Impact factor: 3.451

9.  Cardioprotective Effects of Remifentanil in a Sympathetic Hyperactivity Model in Rabbits.

Authors:  Selen Bayındır; Necati Gökmen; Serhat Erbayraktar; Semih Küçükgüçlü; Osman Yılmaz; Ömer Şahin; Elvan Öçmen; Hale Aksu Erdost; Emel Sağıroğlu
Journal:  Turk J Anaesthesiol Reanim       Date:  2015-03-03

10.  Acute methadone treatment reduces myocardial infarct size via the delta-opioid receptor in rats during reperfusion.

Authors:  Eric R Gross; Anna K Hsu; Garrett J Gross
Journal:  Anesth Analg       Date:  2009-11       Impact factor: 5.108

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.